With Novo Nordisk Dependent On GLP-1s, Even Perceived Price Pressures Can Hurt

 
• By Sten Stovall
  
Price
Novo Nordisk foresees basal insulin prices being squeezed further in 2019 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip